Header Logo

Connection

Stanley Hsia to Amylin Receptor Agonists

Back to Details
This is a "connection" page, showing publications Stanley Hsia has written about Amylin Receptor Agonists.
Stanley Hsia
Connection Strength
0.238
Amylin Receptor Agonists
  1. Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2025 Dec 06; 406(10520):2631-2643.
    View in: PubMed
    Score: 0.238
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.